{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:35:54Z","timestamp":1715646954892},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,12]]},"DOI":"10.7759\/cureus.60173","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:59:15Z","timestamp":1715583555000},"source":"Crossref","is-referenced-by-count":0,"title":["A Grover-Like Skin Rash: A Potential Indicator of Underlying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection"],"prefix":"10.7759","author":[{"given":"Gita","family":"Mihelcic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tja\u0161a","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayder N","family":"Alhameedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel  E","family":"Audet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u0161tjan","family":"Leskovar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1970.04000040048010","article-title":"Transient acantholytic dermatosis","volume":"101","author":"Grover RW","year":"1970","unstructured":"Grover RW. Transient acantholytic dermatosis. Arch Dermatol. 1970, 101:426-34. 10.1001\/archderm.1970.04000040048010","journal-title":"Arch Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2004.054_1.x","article-title":"Grover's disease: 34 years on","volume":"45","author":"Quirk CJ","year":"2004","unstructured":"Quirk CJ, Heenan PJ. Grover's disease: 34 years on. Australas J Dermatol. 2004, 45:83-6. 10.1111\/j.1440-0960.2004.054_1.x","journal-title":"Australas J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14202","article-title":"Clinical features and treatments of transient acantholytic dermatosis (Grover's disease): a systematic review","volume":"18","author":"Bellinato F","year":"2020","unstructured":"Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Clinical features and treatments of transient acantholytic dermatosis (Grover's disease): a systematic review. J Dtsch Dermatol Ges. 2020, 18:826-33. 10.1111\/ddg.14202","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.11096","article-title":"Clinicopathological correlation of transient acantholytic dermatosis: a case report","volume":"23","author":"Brihan I","year":"2022","unstructured":"Brihan I, Fekete GL, Turda C, et al.. Clinicopathological correlation of transient acantholytic dermatosis: a case report. Exp Ther Med. 2022, 23:173. 10.3892\/etm.2021.11096","journal-title":"Exp Ther Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54262","article-title":"Acantholytic dyskeratosis consistent with Grover\u2019s disease after letrozole therapy","volume":"16","author":"Mahboob O","year":"2024","unstructured":"Mahboob O, Amawi Y, Alkaelani MT, Mahboob O, Tie C. Acantholytic dyskeratosis consistent with Grover\u2019s disease after letrozole therapy. Cureus. 2024, 16:e54262. 10.7759\/cureus.54262","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5070\/D3262047420","article-title":"BRAF inhibitor and hairy cell leukemia-related transient acantholytic dermatosis","volume":"26","author":"Singh AG","year":"2020","unstructured":"Singh AG, Tchanque-Fossuo CN, Elwood H, Durkin JR. BRAF inhibitor and hairy cell leukemia-related transient acantholytic dermatosis. Dermatology Online Journal. 2020, 26:9-10. 10.5070\/D3262047420","journal-title":"Dermatology Online Journal"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15104","article-title":"Grover-like skin eruption: another cutaneous manifestation in a COVID-19 patient","volume":"59","author":"Boix-Vilanova J","year":"2020","unstructured":"Boix-Vilanova J, Gracia-Darder I, Saus C, Ramos D, Llull A, Santonja C\r\n. Grover-like skin eruption: another cutaneous manifestation in a COVID-19 patient. Int J Dermatol. 2020, 59:1290-2. 10.1111\/ijd.15104","journal-title":"Int J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14700","article-title":"Grover disease: review of subtypes with a focus on management options","volume":"59","author":"Aldana PC","year":"2020","unstructured":"Aldana PC, Khachemoune A. Grover disease: review of subtypes with a focus on management options. Int J Dermatol. 2020, 59:543-50. 10.1111\/ijd.14700","journal-title":"Int J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0703a11","article-title":"Grover's disease: dermoscopy, reflectance confocal microscopy and histopathological correlation","volume":"7","author":"Lacarrubba F","year":"2017","unstructured":"Lacarrubba F, Boscaglia S, Nasca MR, Caltabiano R, Micali G. Grover's disease: dermoscopy, reflectance confocal microscopy and histopathological correlation. Dermatol Pract Concept. 2017, 7:51-4. 10.5826\/dpc.0703a11","journal-title":"Dermatol Pract Concept"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24082","article-title":"Management and treatment of Grover's disease: a case report and review of literature","volume":"14","author":"Sousou JM","year":"2022","unstructured":"Sousou JM, Fritsche JM, Fernandez BR, Tummala MR, Scott R. Management and treatment of Grover's disease: a case report and review of literature. Cureus. 2022, 14:e24082. 10.7759\/cureus.24082","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.041","article-title":"Atypical features and systemic associations in extensive cases of Grover disease: A systematic review","volume":"77","author":"Gantz M","year":"2017","unstructured":"Gantz M, Butler D, Goldberg M, Ryu J, McCalmont T, Shinkai K. Atypical features and systemic associations in extensive cases of Grover disease: A systematic review. J Am Acad Dermatol. 2017, 77:952-957.e1. 10.1016\/j.jaad.2017.06.041","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16672","article-title":"Prevalence of cutaneous manifestations in COVID-19: a meta-analysis","volume":"50","author":"Li J","year":"2023","unstructured":"Li J, Wen W, Mu Z, Du X, Han X. Prevalence of cutaneous manifestations in COVID-19: a meta-analysis. J Dermatol. 2023, 50:622-36. 10.1111\/1346-8138.16672","journal-title":"J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15477","article-title":"COVID-19 and cutaneous manifestations: a review of the published literature","volume":"22","author":"Martora F","year":"2023","unstructured":"Martora F, Villani A, Fabbrocini G, Battista T. COVID-19 and cutaneous manifestations: a review of the published literature. J Cosmet Dermatol. 2023, 22:4-10. 10.1111\/jocd.15477","journal-title":"J Cosmet Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103261","article-title":"Skin manifestations in COVID-19: prevalence and relationship with disease severity","volume":"9","author":"Giavedoni P","year":"2020","unstructured":"Giavedoni P, Podlipnik S, Peric\u00e0s JM, Fuertes de Vega I, Garc\u00eda-Herrera A, Al\u00f3s L. Skin manifestations in COVID-19: prevalence and relationship with disease severity. J Clin Med. 2020, 9:3261. 10.3390\/jcm9103261","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000002150","article-title":"Acantholytic dyskeratosis post-COVID vaccination","volume":"44","author":"Yang K","year":"2022","unstructured":"Yang K, Prussick L, Hartman R, Mahalingam M. Acantholytic dyskeratosis post-COVID vaccination. Am J Dermatopathol. 2022, 44:e61-3. 10.1097\/DAD.0000000000002150","journal-title":"Am J Dermatopathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000002365","article-title":"Unilateral Grover-like skin eruption following Pfizer COVID-19 vaccine","volume":"45","author":"Dadrass F","year":"2023","unstructured":"Dadrass F, Knabel M, Swan J. Unilateral Grover-like skin eruption following Pfizer COVID-19 vaccine. Am J Dermatopathol. 2023, 45:282-84. 10.1097\/DAD.0000000000002365","journal-title":"Am J Dermatopathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.4491","article-title":"Assessment of blue light phototherapy for Grover disease: a nonrandomized controlled trial","volume":"159","author":"Olagbenro M","year":"2023","unstructured":"Olagbenro M, Ravi S, Myers D, Lin D, Woodburn W, Walter JR, Xu S. Assessment of blue light phototherapy for Grover disease: a nonrandomized controlled trial. JAMA Dermatol. 2023, 159:102-4. 10.1001\/jamadermatol.2022.4491","journal-title":"JAMA Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/251086-a-grover-like-skin-rash-a-potential-indicator-of-underlying-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:59:19Z","timestamp":1715583559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/251086-a-grover-like-skin-rash-a-potential-indicator-of-underlying-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,12]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.60173","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,12]]}}}